Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07503769

CHU Dual-Energy Ablation in Ventricular Arrhythmia

Contact-Force Guided Hybrid-Dual-Energy Ultra-Saline-Irrigated Ablation First-in-Man for Ventricular Arrhythmia: CHU VA

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Shanghai MicroPort EP MedTech Co., Ltd. · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the safety of the dual-energy ablation catheter manufactured by Shanghai MicroPort EP Medical Technology Co., Ltd. in the treatment of tachyarrhythmias.

Conditions

Interventions

TypeNameDescription
DEVICEablationAll enrolled subjects will undergo radiofrequency or pulsed ablation for idiopathic ventricular arrhythmias using the investigational catheter.

Timeline

Start date
2026-02-03
Primary completion
2026-07-31
Completion
2026-10-31
First posted
2026-03-31
Last updated
2026-03-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07503769. Inclusion in this directory is not an endorsement.